Surgical and Blood-Based Minimal Residual Disease in Patients with Ovarian Cancer after First-line Therapy: Clinical Outcomes and Translational OpportunitiesAnne Knisely, Amir A. Jazaeri, Helen Clark et al.|Clinical Cancer Research|2025Cited by 10
Prognostic implications of minimal residual disease detection by second-look laparoscopy and circulating tumor DNA among patients with ovarian cancer after front-line therapyAnne Knisely, Amir A. Jazaeri, Sanghoon Lee et al.|Gynecologic Oncology|2024Cited by 1